APP and early-onset autosomal dominant Alzheimer disease: In the last several decades, traditional transgenic mouse models of Alzheimer's disease (AD), such as APP/PSEN1 and 5xFAD, overexpress human mutant amyloid precursor protein (APP) to increase pathological amyloid-β peptide and were widely used in research to develop therapeutic approaches for AD.